By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Venture Life Group plc

Venture Life Group plc (VLG.L)

LSE Currency in GBP
£57.00
-£0.75
-1.30%
Last Update: 16 Jul 2025, 15:35
£72.99M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
£32.00 - £63.00
52 Week Range

VLG.L Stock Price Chart

Explore Venture Life Group plc interactive price chart. Choose custom timeframes to analyze VLG.L price movements and trends.

There is nothing to show.

VLG.L Company Profile

Discover essential business fundamentals and corporate details for Venture Life Group plc (VLG.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

28 Mar 2014

Employees

165.00

CEO

Jeremy Anthony Philip Randall ACA

Description

Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, dermo-cosmetics, and topical products for the ageing population in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. It operates through Venture Life Brands and Customer Brands segments. The company offers neurology products, including NeuroAge, NeuroAge Sleep, and NeuroAge NRG food supplements to enhance alertness, cognitive function, and mental performance in healthy brain; and Original Bioscalin to treat and prevent hair loss, hair thinning, and baldness. It also provides Fungal Nail Solution, which helps to treat and prevent fungal infections; and Fungal Nail Cleanser for the hygiene of hands and feet prone to fungal nail infections under the Myco Clear brand name. In addition, the company offers UltraDEX product for bad breath; Dently Dual Action, a mouthwash, which lifts and removes plaque and bacteria from the teeth and gums; and Procto-eze plus for anal irritation, including haemorrhoids condition. Further, it provides women healthcare products comprising vonalei bacterial vaginosis, a refreshing gel; vonalei Vaginal Atrophy, a vaginal cream; vonalei candidiasis, a soothing cream-gel for thrush; and vonalei intimate cleansing foam. Additionally, it offers Cleansing Foam, Cleansing Cream, and Serum under the Rosa calma brand name; and skincare ranges to hydrate, nourish, and recondition the skin, as well as to prevent the lines and wrinkles under the Lubatti Classic and the Lubatti Anti-age brand names. The company sells its products through a network of international partners, retail pharmacies, as well as grocery multiple retailers. Venture Life Group plc was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.

VLG.L Financial Timeline

Browse a chronological timeline of Venture Life Group plc corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 29 Sept 2025

Earnings released on 19 Jun 2025

Revenue for the quarter reached £26.82M, missing expectations by -5.23%.

Earnings released on 30 Sept 2024

EPS came in at -£0.01, while revenue for the quarter reached £23.45M, missing expectations by -0.20%.

Earnings released on 9 Apr 2024

EPS came in at £0.02, while revenue for the quarter reached £27.96M, beating expectations by +2.40%.

Earnings released on 27 Sept 2023

EPS came in at -£0.01, while revenue for the quarter reached £23.45M, missing expectations by -0.20%.

Earnings released on 6 Apr 2023

EPS came in at £0.01, while revenue for the quarter reached £25.12M, beating expectations by +11.64%.

Earnings released on 29 Jun 2022

EPS came in at -£0.00, while revenue for the quarter reached £18.86M, missing expectations by -0.21%.

Earnings released on 30 Dec 2021

EPS came in at £0.02, while revenue for the quarter reached £18.90M, beating expectations by +1.05%.

Earnings released on 29 Jun 2021

EPS came in at -£0.00, while revenue for the quarter reached £13.87M, beating expectations by +0.48%.

Earnings released on 30 Dec 2020

EPS came in at £0.01, while revenue for the quarter reached £13.18M, missing expectations by -1.35%.

VLG.L Stock Performance

Access detailed VLG.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
VLG.L
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
VLG.L
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More